Liraglutide achieved an 8% weight loss over 56 weeks (Pi-Sunyer et al., 2015), while semaglutide resulted in a 15% reduction over two years (Wharton et al., 2023)
Answer: In a 48-week phase 2 trial, participants on the highest retatrutide doses lost up to roughly 24 percent of body weight, a figure that exceeded results reported for currently approved single and dual agonists
On average, tirzepatide produces more weight loss in head-to-head studies
Peptide SPPS & liquid phase Small-molecule synthesis Process optimisation Reference standards 02 Manufacturing A self-developed pharmaceutical raw-material production line across a 50,000 m site reactor trains, chromatographic purification, lyophilisation and controlled filling
Same medication (semaglutide), different delivery